The results from this multi-site, blinded study are in. The CiPA team conclusively demonstrated the utility of human stem cell-derived cardiomyocytes to detect drug-induced arrhythmia effects. We are proud that the Maestro MEA system played a pivotal role in the study. More importantly, we are thankful for all the Maestro MEA users at big pharma for making us look great.
CiPA: The Results Axion BioSystems
